Company: SXTPW
Filing Date: 2025-06-06
Form Type: DRS
Source: 0001213900-25-052232
Chunk: 2

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-06-06
Form: DRS
Chunk 2
---
 of Common Stock Issuable Upon Exercise of the Series A-1 Warrants, Series A-2 Warrants and Pre-Funded Warrants

60 Degrees Pharmaceuticals, Inc.</div>

We are offering up to shares
of common stock, par value $0.0001 per share, together with accompanying Series A-1 warrants (the “Series A-1 Warrants”) to
purchase up to shares of common stock, and Series
A-2 Warrants (the “Series A-2 Warrants,” and together with the Series A-1 Warrants, the “Warrants”) to purchase
up to shares of common stock, pursuant to this
prospectus. The combined assumed public offering price for each share of common stock and accompanying Series A-1 Warrant and Series A-2
Warrant is $ , which is equal to the last reported
sale price of our common stock on The Nasdaq Capital Market on
, 2025. Each Warrant will have an assumed exercise price of $ per
share, will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the
Warrants (“Warrant Stockholder Approval”), provided, however, if the Pricing Conditions (as defined below) are met, the Warrants
will be exercisable upon issuance (the “Initial Exercise Date”). The Series A-1 Warrant will expire on the
anniversary of the Initial Exercise Date. The Series A-2 Warrant will expire on the
anniversary of the Initial Exercise Date. The shares of common stock and accompanying Warrants are immediately separable and will be issued
separately in this offering. As used herein “Pricing Conditions” mean that the combined offering price per share and accompanying
Warrants is such that the Warrant Stockholder Approval is not required under the rules of The Nasdaq Stock Market LLC (“Nasdaq”)
because either (i) the offering is an at-the-market offering under Nasdaq rules and such price equals or exceeds the sum of (a) the applicable
“Minimum Price” per share under Nasdaq Listing Rule 5635(d) plus (b) $0.125 per whole share of common stock underlying the
Warrants or (ii) the offering is a discounted offering where the pricing and discount (including attributing a value of $0.125 per whole
share underlying the Warrants) meet the pricing requirements under Nasdaq’s rules.

We are also offering pre-funded warrants (the